# Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy

> **NCT02563665** · — · WITHDRAWN · sponsor: **Institute of Liver and Biliary Sciences, India**

## Conditions studied

- CKD With Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02563665
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funds
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02563665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02563665, "Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02563665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*